This review focuses on the studies concerning the predictive role of two circulating biomarkers of tissue ischemia, high-sensitivity cardiac troponin (hs-cTn) and ischemia-modified albumin (IMA), in patients with PAD. The gene discussed is ALB; the disease is peripheral arterial disease.